Metrics Contract Services, a division of Mayne Pharma, specializes in a wide array of advanced pharmaceutical technologies aimed at enhancing drug delivery and formulation. Their offerings include oral dose development, bioavailability enhancement, and integrated development solutions. Notable technologies include the OptiForm® Solution Suite and Catalent Xpress Pharmaceutics®, which facilitate the design and optimization of oral dosage forms such as tablets, capsules, and softgels. The company also emphasizes bioavailability enhancement through modified release formulations and abuse deterrent technologies, ensuring that their products meet diverse therapeutic needs while maintaining safety and efficacy.

In addition to oral technologies, Metrics Contract Services provides comprehensive services for highly potent active pharmaceutical ingredients and biologics. Their capabilities extend to specialty inhalation technologies, including nasal delivery and dry powder inhalers, as well as small molecule injectables. The company is committed to offering end-to-end solutions that encompass analytical services, stability testing, and regulatory support, thereby streamlining the drug development process from preclinical stages to commercial manufacturing. This integrated approach positions Metrics Contract Services as a key player in the pharmaceutical industry, capable of addressing the complexities of modern drug development.

United States

Metrics Contract Services is a North Carolina-based CDMO that offers services such as formulation development, analytical testing, and drug manufacturing for the pharmaceutical industry.

Metrics Contract Services (Mayne Pharma)

Company Details